Dr. Jayant Kumar, MD

Dr. Kumar practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Kumar's NPI, 1558451039, was assigned on October 13, 2006. Dr. Kumar graduated from All India Institute of Medical Sciences in 1990. Dr. Kumar holds New Mexico license MD2007-0729.

Dr. Kumar's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Kumar's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Kumar is also affiliated with Lovelace Medical Center. The medical group on file is Renal Medicine Associates. Dmand AI also links Dr. Kumar to 3 more hospitals, 3 dialysis centers, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kumar is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Kumar's licenses on file in 3 states: New Mexico, California and Arkansas.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Kumar treats.

CMS data shows 1,365 Medicare services from Dr. Kumar across 11 procedure codes in 2024, for 413 Medicare patients. Medicare paid $265,708 for them.

CMS counts 413 Medicare patients who saw Dr. Kumar in 2026. The largest group is 65 to 74, with 146 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 4.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 67, with 50% women.

In 2026, Dr. Kumar wrote 2,361 Medicare Part D claims for 332 patients. 86% of them were for generic drugs. CMS names the drug for 2,064 of them, across 49 drugs with 11 or more claims each, at $261,388 in total drug cost. In 2023, CMS named 1,724 claims across 42 drugs.

Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth.

Dmand AI links 29 papers to Dr. Kumar, published from 2016 to 2024. 2017 was the busiest year, with 7. The most frequent topics are Kidney Transplantation, Liver and Postoperative Complications. Dr. Kumar has published most often in Eur J Trauma Emerg Surg. Dr. Kumar's most frequent co-authors are Bart Barlogie, MD, Rajiv Agarwal, MD and Rajiv Agarwal.

Dmand AI links Dr. Kumar to 11 clinical trials, 5 of them phase 3 studies. Conditions studied include Renal Insufficiency, Chronic, Renal Insufficiency and Diabetic Nephropathies. Astellas Pharma Europe B.V. sponsors the most, 2.

CMS Open Payments shows 369 general payments to Dr. Kumar from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Fresenius USA Marketing, Inc. paid the most, $3,773. It also lists 1 research payment totaling $25,692 in 2016.

Dmand AI lists 1 award for Dr. Kumar, most recently Regional Top Doctor in 2024.

Dr. Kumar graduated from All India Institute of Medical Sciences in 1990.

Dr. Kumar is in network with 11 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.